$0.00
(+0.00%
) Quote detailsUSD
+$0.00
(+0.00%
)At Close (As of Oct 14, 2025)
$19.65M
Market Cap
-
P/E Ratio
-0.09
EPS
$1.96
52 Week High
$0.89
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Synlogic, Inc. is an innovative clinical-stage biopharmaceutical company headquartered in Cambridge, Massachusetts, dedicated to developing synthetic biotic drugs aimed at transforming the treatment landscape for cancer, inflammatory, and metabolic diseases. With a proprietary platform that harnesses the power of engineered probiotics, Synlogic's pipeline includes several novel therapeutic candidates designed to provide targeted treatment solutions with enhanced efficacy and safety profiles. The company's commitment to advancing its synthetic biotic technology positions it at the forefront of a rapidly evolving field, appealing to institutional investors seeking growth opportunities in biotechnology.